Nicotinamide for Prevention of Pre-malignant Actinic Keratosis in Kidney Transplant Recipients

NCT04843553 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Actinic Keratoses

Interventions

DRUG: Oral Nicotinamide

Sponsor

Rhode Island Hospital